Long-Term Epoprostenol Therapy in Pulmonary Artery Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-Term Epoprostenol Therapy in Pulmonary Artery Hypertension

Published:2009 Issue:3 Volume:73 Page:523-529
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Sakuma Masahito¹,Demachi Jun²,Nawata Jun³,Suzuki Jun⁴,Takahashi Tohru⁵,Shirato Kunio⁶

Affiliation:

1. Division of Internal Medicine, Onagawa Municipal Hospital

2. Department of Cardiology, Ishinomaki Municipal Hospital

3. Division of Internal Medicine, Nakajima Hospital

4. Department of Internal Medicine, Kurihara Central Hospital

5. Department of Cardiology, Iwate Prefectural Central Hospital

6. Division of Internal Medicine, Saito Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/73/3/73_CJ-07-1020/_pdf

Reference10 articles.

1. 1. Rubin LJ, Mendoza J, Hood M, McGoon M, Barst R, Williams WB, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): Results of a randomized trial. Ann Intern Med 1990; 112: 485-491.

2. 2. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996; 334: 296-302.

3. 3. McLaughlin VV, Shillington RN, Rich S. Survival in primary pulmonary hypertension: The impact of epoprostenol therapy. Circulation 2002; 106: 1477-1482.

4. 4. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-788.

5. 5. Nakayama T, Shimada H, Takatsuki S, Hoshida H, Ishikita T, Matsuura H, et al. Efficacy and limitations of continuous intravenous epoprostenol therapy for idiopathic pulmonary arterial hypertension in Japanese children. Circ J 2007; 71: 1785-1790.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Initiation of Intravenous Epoprostenol Infusion Is the Favored Option in Patients with Advanced Pulmonary Arterial Hypertension;PLOS ONE;2015-04-06

2. Marked Hemodynamic Improvements by High-Dose Epoprostenol Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension;Circulation Journal;2010

3. Dose-Dependent Reduction in Pulmonary Vascular Resistance With Epoprostenol in Pulmonary Arterial Hypertension;Circulation Journal;2010

4. Meta-Analysis of Randomized Controlled Trials on Treatment of Pulmonary Arterial Hypertension;Circulation Journal;2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3